Healthcare

PetVivo Holdings, Inc. Addresses Veterinary Industry’s GEN Z Problem With Breakthrough AI License Agreement

PetVivo Holdings, Inc. New Invite from Dawn's Pet Care MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:…

2 months ago

Konica Minolta Healthcare Receives Innovative Technology Designation from Vizient for Dynamic Digital Radiography

Dynamic Digital Radiography - Shoulder Series DDR is a novel, low-dose X-ray imaging technique available on Konica Minolta Healthcare DR…

2 months ago

Novo Nordisk announces an Extraordinary General Meeting to be convened to elect new members of the Board of Directors

Bagsværd, Denmark, 21 October 2025 - Novo Nordisk today announced that the Board of Directors have decided to convene an Extraordinary…

2 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Collaboration with MSK’s Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of the Bria-OTS+™ platform, which includes Bria-BRES+™…

2 months ago

Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch

Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025…

2 months ago

InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…

2 months ago

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

Charles “Chip” Romp and Tom Heyman join SynOx’s Board, bringing deep launch, lifecycle, and corporate development expertise as the company…

2 months ago

Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment,…

2 months ago

TempraMed Announces Private Placement of up to C$2.5 Million

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce…

2 months ago

Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges

PALO ALTO, CA / ACCESS Newswire / October 21, 2025 / Bioz, Inc., a pioneering AI platform changing the way…

2 months ago